US 9827295
Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase
granted A61KA61K38/47A61K48/00
Quick answer
US patent 9827295 (Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase) held by Regents of the University of Minnesota expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/47, A61K48/00, A61P, A61P25/00